PRC2 on its promoter targets (Fig. 1a) , keeping Stat3-binding sites accessible in the pluripotent genome. On LIF-signalling stimulation, Stat3 is phosphorylated and enters the nucleus to bind target genes (Fig. 1a) , enabling the derivation of pluripotency. Ho et al. also demonstrate that the binding of Stat3 reinforces the binding of esBAF to their common targets, keeping many binding sites accessible. In the absence of Brg1, PRC2 adds the H3K27me3 histone modification, rendering Stat3 target genes inaccessible for transcription (Fig. 1b) .
However, the antagonistic regulation between esBAF and the polycomb complex is not the only mode of interaction between these two determinants. A decrease in H3K27me3 was detected in Brg-KO ESCs among genes that predominantly promote differentiation (for example, Hox genes) and are repressed by Brg (Fig. 1c) . Therefore it seems that esBAF also acts synergistically with PRC2 to silence target genes that may, when activated, disrupt the pluripotency gene network (Fig. 1c) . Notably, the molecular basis underlying recruitment of esBAF and PRC2 complexes to Stat3-binding sites and dictating synergistic versus antagonistic regulatory activity in a targetgene-specific manner remains undefined.
These findings raise further mechanistic questions regarding the links between pluripotency and epigenetic reprogramming. LIF/Stat3 signalling not only maintains stable propagation of newly formed iPSCs, but also cooperates with the ectopically expressed reprogramming transcription factors (for example, Oct4, Sox2, Klf4 and c-Myc) to directly contribute to the induction and reactivation of the endogenous naive pluripotency network in somatic cells 5 . Whether Stat3 sites can become accessible during iPSC reprogramming in the absence of LIF/ Stat3 signalling, and whether BAF complex reconfiguration and the adequate assembly of the ESC-specific esBAF during reprogramming is a critical rate-limiting step in the process are questions that remain to be answered. Given that LIF/Stat3 signalling is a predominant factor in the epigenetic reversion of developmentally restricted primed epiblast stem cells (EpiSCs) back to naive pluripotency 1, 5, 12 , it would be interesting to characterize esBAF configuration in EpiSCs and to test whether this complex can regulate the EpiSC-specific signalling pathways, as EpiSCs rely on basic fibroblast growth factor (bFGF) and activin/nodal, rather than LIF/Stat3, signalling for their maintenance. LIF/Stat3 signalling has recently been shown to contribute to the generation of naive human pluripotent cells that share defining features with naive mouse ESCs 13 , raising the obvious question of whether esBAF composition and roles in transcription are conserved between mice and humans. Finally, given that Stat3 is dispensable for the establishment of ground-state pluripotency in vivo within the ICM 14 , and that naive murine ESCs can be grown in the absence of exogenous Stat3 signalling through the combined inhibition of bFGF, ERK and GSK3β signalling pathways (termed '3i' conditions 14 ), it would be insightful to elucidate whether and how esBAF facilitates pluripotency in these settings.
This work highlights the shortcomings and limitations of static profiling of binding and chromatin marks at a fixed cellular state 15 , and elegantly demonstrates the additional insights that can be learned from using relevant dynamic in vitro experimental models that allow controlled and temporal introduction of defined genetic perturbations, followed by precise measurements of biochemical and molecular outcomes. Such stemcell-based experimental models are making notable contributions to our understanding of the cellular and molecular mechanisms that govern developmental biology.
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FBXW5 controls centrosome number

Julia Pagan and Michele Pagano
Regulatory mechanisms to prevent centriole overduplication during the cell cycle are not completely understood. In this issue, FBXW5 is shown to control the degradation of the centriole assembly factor HsSAS-6. Moreover, the study proposes that FBXW5 is a substrate of both PLK4 and APC/C, two established regulators of centriole duplication.
Centrioles are fundamental for the assembly of microtubule-based structures, including cilia, flagella and the centrosome 1 . Abnormalities in centriole structure and function are associated with a number of diseases, including ciliopathies, obesity, primary microcephaly, male sterility and cancer. Not surprisingly, centriole duplication is exquisitely regulated and coordinated with the cell cycle. Each S phase, only one new centriole (termed a procentriole) is assembled from the lateral surface of the two preexisting centrioles. The procentriole elongates until early mitosis and remains attached to its parental centriole until they disengage (that is, they lose their orthogonal configuration) in late mitosis. It is only after disengagement that centrioles are able to nucleate procentrioles 2 . In addition, to ensure centriole 'copy number control' 1 , cells tightly regulate the levels and activity of centriole assembly factors.
PLK4, a divergent member of the Polo-like kinase family, is considered the master regulator of centriole copy number. Its levels and activity correlate with centriole number, both in model organisms and mammalian cells 3 . Depletion of PLK4 leads to the loss of centrioles with successive cell divisions, while, remarkably, overexpression of PLK4 produces multiple bona fide procentrioles around the parental centriole, in a rosette configuration 3 . Several assembly factors are required downstream of PLK4, including CPAP, CEP135, CEP152, CP110 and HsSAS-6 (ref. 4) . Of these proteins, HsSAS-6 is recruited at the earliest stage of centriole formation 5 , and fascinating recent work suggests that it self-assembles into coiled-coil-containing oligomers that are critical for the initial steps of centriole structure formation 6, 7 . Similarly to PLK4, HsSAS-6 is rate-limiting for centriole duplication, and its overexpression can also induce the formation of multiple procentrioles 8 . The anaphase-promoting complex/cyclosome (APC/C) and the SKP1-CUL1-F-box protein (SCF) complex, two key ubiquitin ligase families involved in progression through the cell cycle, regulate the levels of several centrosome duplication factors. The APC/C is regulated by an interaction with either of two co-activating subunits, CDC20 or CDH1, which target substrates during M phase and G1 phase. APC/C-CDH1 induces the degradation of HsSAS-6 in G1 to restrict centriole duplication from occurring too early in the cell cycle 8 .
Other notable APC/C substrates involved in the centrosome cycle include Cyclin A, Aurora A and PLK1. In contrast to the APC/C, which forms only two complexes, the SCF core scaffold can be used to assemble approximately 69 different complexes based on the recruitment, through SKP1, of a variable F-box protein that confers substrate specificity. A fundamental role for the SCF at the centrosome was initially highlighted by the localization of the core SCF components, SKP1 and CUL1, at interphase and mitotic centrosomes 9 . Moreover, interfering with SCF function by expression of a dominant-negative CUL1 mutant drives centrosome overduplication both in cell systems and a mouse model 10 . Specific F-box proteins implicated in the regulation of centrosome number include FBXW7, SKP2, Cyclin F (also called FBXO1) and βTrCP (see Fig. 1 ). FBXW7 and SKP2 regulate the levels and activity of Cyclin E, a critical coordinator of the centrosome duplication cycle. FBXW7 directly targets Cyclin E for degradation, whereas SKP2-based regulation of Cyclin E is indirect, through the degradation of p27, an inhibitor of Cyclin E-CDK (cyclin-dependent kinase) complexes. More recently, the F-box protein Cyclin F was shown to induce the degradation of the essential centriole duplication factor CP110, to prevent centriole overduplication in G2 phase 11 . Finally, βTrCP plays a critical role in the regulation of centriole number by promoting PLK4 turnover. PLK4 transautophosphorylation creates a phosphodegron recognized by SCF-βTrCP, establishing an important feedback mechanism to control PLK4 levels and limit centriole duplication to once per division 12 . Accordingly, βTrcp1
-/-mouse embryonic fibroblasts display centrosome overduplication 13 . On page 1004 of this issue, Malek and colleagues now show that SCF-FBXW5 is an important negative regulator of centrosome overduplication and propose that this occurs through its regulation of HsSAS-6 levels 14 . Cells depleted of FBXW5 accumulate supernumerary centrioles, multipolar spindles in mitosis and have increased levels of HsSAS-6. Conversely, the overexpression of FBXW5 inhibits centriole duplication and decreases the half-life of HsSAS-6. FBXW5 activity, and by inference the level of HsSAS-6, is regulated by two separate regulatory circuits. First, FBXW5 levels are kept low during mitosis and G1 by the APC/C. Second, to prevent premature FBXW5-mediated degradation of HsSAS-6 during S phase, the authors propose an intriguing mechanism whereby PLK4-mediated phosphorylation of FBXW5 on Ser 151 protects HsSAS-6 from degradation by inhibiting the ubiquitylating activity of SCF-FBXW5, although how this inhibition occurs is unclear.
FBXW5 depletion can only partially rescue the centriole phenotype caused by depletion of PLK4, so FBXW5 is likely to be one of several important PLK4 substrates involved in centriole duplication. Several other targets of PLK4 phosphorylation that are involved in centriole assembly have been proposed. Of relevance, in Caenorhabditis elegans it was recently found that ZYG-1 (the C. elegans orthologue of PLK4) phosphorylates SAS-6 at Ser 123, and this phosphorylation is critical for centriole duplication 15 . Perhaps PLK4 is involved in multiple layers of regulation of HsSAS-6, both directly and indirectly through the inhibition of FBXW5. SAS-6 Ser 123 is not a conserved residue in HsSAS-6, suggesting that if HsSAS-6 is a substrate of PLK4 in mammalian cells, the site required for regulation is different. Beyond SAS-6, other proposed substrates of PLK4 include CPAP and CEP152 (ref. 16 ), both of which are important centriole assembly factors required downstream of PLK4.
A number of important questions remain regarding the pathway proposed by Malek and colleagues. Firstly, how does FBXW5 target HsSAS-6 for degradation? Identification of the degron in HsSAS-6 would provide powerful information about how FBXW5 recognizes its substrates, and it would establish if HsSAS-6 recognition by FBXW5 is phosphorylation dependent, as substrate recognition by F-box proteins generally (although not always 11 ) requires phosphorylation. Such details may reveal additional regulatory mechanisms, such as the kinase pathway for the phosphodegron, and thus information about the spatiotemporal regulation of HsSAS-6 degradation by FBXW5. Secondly, does FBXW5 reside exclusively at the centrosome, and if so, does it localize to a specific centrosomal substructure? The authors were unable to localize FBXW5 at the centriole by standard immunofluorescence microscopy analysis, although they showed that FBXW5 is present in centrosomeenriched fractions. The previously published substrates for FBXW5, TSC1 and TSC2, have no published role in centriole duplication and have not been shown to localize on the centrosome 17 , which may suggest regulated localization of FBXW5. Thirdly, it will be important for future work to establish the spatiotemporal dynamics of FBXW5 Ser 151 phosphorylation in vivo using phosphospecific antibodies. According to the authors' model, Ser 151 phosphorylation should occur in the early stages of S phase to ensure that sufficient HsSAS-6 levels are protected for the initiation of centriole duplication. Lastly, it would be interesting to understand the mechanism by which phosphorylation inhibits the ligase activity of SCF-FBXW5 to shed light on the regulation of F-box proteins by post-translational modifications. Does phosphorylation influence binding between HsSAS-6 and FBXW5, or does it affect the catalytic activity of SCF-FBXW5? It will be important to investigate this mechanism in more detail, employing both phosphomimic and phosphodefective forms of FBXW5 in assays for its cell cycle levels, localization, substrate binding etc.
Clearly, tight regulation of the levels of centriole assembly factors is required to maintain the correct number of centrioles within a cell. Defects in this process lead to abnormal numbers of centrioles, a state that is associated with aneuploidy and is a hallmark of many cancer cells. Malek and colleagues have provided insight into a novel regulatory pathway controlling the levels of HsSAS-6 and centriole numbers. Increasing our understanding of the role of proteolysis pathways at the centrosome, such as the interplay between HsSAS-6, FBXW5 and PLK4, will undoubtedly enhance our understanding of the centriole duplication process.
